Shiva Malaty
Rheumatology · Gilbert, AZNPI 1255892154
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations.
Across 165 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$679
- AbbVie$641
- Amgen$640
- Mallinckrodt Hospital Products Inc.$311
- Octapharma USA, Inc.$298
- Johnson & Johnson$241
- plus $842 from 13 others
What the payments were for
- Food & beverage$3,652100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 24 | $679 |
| AbbVie | 31 | $641 |
| Amgen | 36 | $640 |
| Mallinckrodt Hospital Products Inc. | 15 | $311 |
| Octapharma USA, Inc. | 8 | $298 |
| Johnson & Johnson | 11 | $241 |
| AstraZeneca(2 entities) | 7 | $134 |
| Pfizer | 5 | $129 |
| Radius Health, Inc. | 5 | $128 |
| Sobi, Inc | 4 | $82 |
| E.r. Squibb & Sons, L.L.C. | 3 | $75 |
| Sanofi | 3 | $64 |
| Organon | 4 | $51 |
| Fidia Pharma USA Inc. | 2 | $43 |
| Genentech USA, Inc. | 2 | $37 |
| Novartis | 2 | $37 |
| Boehringer Ingelheim | 1 | $26 |
| Biocon Biologics Inc | 1 | $19 |
| GSK | 1 | $17 |
How this compares
$3,652 in reported general payments places this provider in the 55th percentile of 102 rheumatology providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $293,940 |
| Leflunomide | 11 | $2,269 |
| Hydroxychloroquine Sulfate | 29 | $1,622 |
| MethotrexateMethotrexate Sodium | 47 | $1,152 |
| Prednisone | 31 | $295 |
| Folic Acid | 20 | $229 |
| Sodium Chloride0.9 % Sodium Chloride | 13 | $196 |
| Allopurinol | 11 | $167 |
| Meloxicam | 16 | $149 |
| Alendronate Sodium | 13 | $106 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Gilbert
- Brittany PanicoGilbert$374K
- Joon Hee LimGilbert$35K
- Daniel KreutzGilbert$27K
- Nehad SolomanPhoenix$1.3M
- John TesserPhoenix$999K
- Joy SchechtmanPeoria$860K
- Mona AminGlendale$446K
- Amer Al-KhoudariChandler$369K
- Andrew SharobeemGlendale$231K
- Paul HowardScottsdale$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.